Диссертация_Яковлев_ДА. Диссертация на соискание ученой степени кандидата медицинских наук Научный доктор медицинских наук, профессор Немков Александр Сергеевич
 Скачать 2.26 Mb.
|
|
36. Arends M., Wyllie A. Apoptosis: Mechanisms and roles in pathology. // Int. Rev. Exp. Pathol. – 1991. – Vol. 136. – P. 223 – 54. 37. Baer F., Erdmann E. Methods of assessment and clinical relevance of myocardial hibernation and stunning. Assessment of myocardial viability. // Thorac. Cardiovasc. Surg. – 1998. – Vol. 46. – Suppl.2. – P. S264 – S269. 148 38. Baer F., Theissen P., Schneider C., et al. MRI assessment of myocardial viability: comparison with other imaging techniques. // Rays. – 1999. – Vol.24. – P.96 – 108. 39. Baker W., Klein M., Reardon M., et al. Reversible cardiac dysfunction (hibernation) from ischemia due to compression of the coronary arteries by a pseudoaneurysm. // N. Engl. J. Med. – 1991. – Vol. 325. – №26. – P. 1858– 1861. 40. Barnes E., Dutka D., Khan M., Camici P., et al. Effect of repeated episodes of reversible myocardial ischemia on myocardial blood flow and function in humans. // Am. J. Physiol. Heart Circ. Physiol. – 2002. – Vol.282. – P. H1603–H1608. 41. Bax J., Cornel J., Poldermans D., et al. Myocardial tissue vitality: clinical relevance, pathophysiology and identification. // Ned. Tijdschr. Geneeskd. – 1998. – Vol.142 – №2. – P. 67-71. 42. Bax J., Poldermans D., Elhendy A., et al. Assessment of myocardial viability by nuclear imaging techniques. // Curr. Cardiol. Rep. – 2005. – Vol.7. – P. 124 – 129. 43. Bax J., Poldermans D., van der Wall. Evaluation of hibernating myocardium. // Heart. – 2004. – Vol.90. – №11. – P.1239 – 1240. 44. Bax J., Visser F., Poldermans D., et al. A time course of functional recovery of stunned and hibernating segments after surgical revascularization. // Circulation. – 2001. – Vol.104. – Suppl.1. – P. I-314 – I-318. 45. Bax J.J., Schinkel A., Boersma E., et al. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. // Circulation. – 2004. – Vol. 110. – Suppl.2. – P. II-18 – II-22. 46. Beanlands R., Nichol G., Huszti E., et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease. A randomized, 149 controlled trial (PARR-2). // J. Am. Coll. Cardiol. – 2007. – Vol. 50. – №. 20. – P. 2002 – 2012. 47. Beanlands R., Ruddy T., deKemp R., et al. Positron emission tomography and recovery following revascularization (PARR-1) : the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. // J. Am. Coll. Cardiol. – 2002. – Vol. 40. – №. 10. – P. 1735 – 1743. 48. Beck C. The development of a new blood supply to the heart by operation. // Ann. Surg., 1935. – Vol.5. – P. 801 – 814. 49. Beller G. Noninvasive assessment of myocardial viability. // The New Engl. J. of Med. – 2000. – Vol. 343. – № 20. – P. 1487 – 1490. 50. Berman D., Hachamovitch R., Shaw L., et al. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: assessment of patients with suspected coronary artery disease. // J Nucl Med. – 2006. – Vol. 47. – P. – 74–82. 51. Bito V., Heinzel F., Weidemann F., et al. Cellular mechanisms of contractile dysfunction in hibernating myocardium. // Circulation Research. – 2004. – Vol. 94. – № 6. – P. 794 – 801. 52. Bolli R. Basic and clinical aspects of myocardial stunning. // Prog. Cardiovasc. Dis. – 1998. – Vol.40. – № 6. – P.477 – 516. 53. Bolli R. Mechanism of myocardial "stunning". // Circulation. – 1990. – Vol. 82. – № 3. – P. 723 – 738. 54. Bolli R. Myocardial "stunning" in man. // Circulation. – 1992. – Vol.86. – № 6. – P.1671 – 1691. 55. Bolli R. Preconditioning: a paradigm shift in the biology of myocardial ischemia. // Am. J. Physiol. Heart. Circ. Physiol. – 2007. – Vol. 292. – № 1. – P. H19 – H27. 56. Bolli R. Why myocardial stunning is clinically important. // Basic Res. Cardiol. – 1998. – Vol. 93. – № 3. – P. 169 – 172. 150 57. Bolli R., Marban E. Molecular and cellular mechanisms of myocardial stunning. // Physiol. Rev. – 1999. – Vol.79. – P. 609 – 634. 58. Bondarenko О., Beek A., Twisk J., et al. Time course of functional recovery after revascularization of hibernating myocardium: a contrast-enhanced cardiovascular magnetic resonance study. // Europ. Heart J. – 2008. – Vol.29. – № 16. – P. 2000 – 2005. 59. Bonow R. Identification of viable myocardium. // Circulation. – 1996. – Vol. 94. – № 11. – P. 2674 – 2680. 60. Bontemps L., Nazzi M., Gabain M., et al. Theoretical model for myocardial functional characterization: application to a group of patients evaluated before and after surgical revascularization. // J. Nucl. Cardiol. – 1998. – Vol. 5. – № 2. – P. 134 – 143. 61. Bourque J., Hasselblad V., Velazquez E., et al. Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta- analysis. // Am. Heart J. – 2003. – Vol. 146. – № 4. – P. 621 – 627. 62. Braunwald B., Kloner R. The stunned myocardium: prolonged, postischemic ventricular dysfunction. // Circulation. – 1982. – Vol. 66. – № 6. – P. 1146 – 1149. 63. Braunwald B., Rutherford J. Reversible ischemic left ventricular dysfunction: evidence for the ‘‘hibernating myocardium’’. // J. Am. Coll. Cardiol. – 1986. – Vol. 8. – № 6. – P. 1467 –1470. 64. Buja L., Eigenbrodt M., Eigenbrodt E., et al. Apoptosis and necrosis: basic types and mechanisms of cell death. // Arch. Pathol. Lab. Med. – 1993. – Vol. 117. – P. 1208 – 1214. 65. Camici P., Dutka D. Repetitive stunning, hibernation, and heart failure: contribution of PET to establishing a link. // Am. J. Physiol. Heart Circ. Physiol. – 2001. – Vol. 280. – № 3. – Р. H-929 – H-936. 66. Camici P., Prasad S., Rimoldi O., et al. Stunning, hibernation, and assessment of myocardial viability. // Circulation. – 2008. – Vol.117. – № 1. – P. 103 – 114. 151 67. Camici P., Rimoldi O. Blood flow in myocardial hibernation. // Curr. Opin. Cardiol. – 1998. – Vol.13. – № 6. – P. 409 – 414. 68. Camici P., Rimoldi O. The clinical value of myocardial blood flow measurement. // J. Nucl. Med. – 2009. – Vol. 50. – P. 1076 – 1087. 69. Camici P., Rimoldi O. Myocardial hibernation vs repetitive stunning in patients. // Cardiol. Rev. – 1999. – Vol. 7. – № 1. – P. 39 – 43. 70. Carluccio E., Biagioli P., Alunni G., et al. Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization. // J. Am. Coll. Cardiol. – 2006. – Vol. 47. – № 5. – P. 969 – 977. 71. Carr J., Haithcock B., Paone G., et al. Long-term outcome after coronary artery bypass grafting in patients with severe left ventricular dysfunction. // Ann. Thorac. Surg. – 2002. – Vol.74. – № 5. – P. 1531 – 1536. 72. Chareonthaitawee P., Gersh B., Araoz Ph., et al. Revascularization in severe left ventricular dysfunction. The role of viability testing. // J. Am. Coll. Cardiol. – 2005. – Vol. 46. – P. 567 –574. 73. Chatterjee K., Swan H., Parmley W., et al. Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary disease. // Circulation. – 1973. – Vol. 47. – № 2. – P. 276 – 286. 74. Chen C., Chen L., Fallon J.T., et al. Functional and structural alterations with 24 hour myocardial hibernation and recovery after reperfusion: A pig model of myocardial hibernation. // Circulation. – 1996. – Vol. 94. – № 3. – P. 507 – 516. 75. Chen W., Li B., Kajstura J., et al. Stretch-induced programmed myocyte cell death. // J. Clin. Invest. – 1995. – Vol. 96. – P. 2247 – 2259. 76. Cokkinos V. Myocardial protection in man—from research concept to clinical practice. // Heart Fail. Rev. – 2007. – Vol. 12. – P. 345 – 362. 77. Coma-Canella I., Velloso M. Clinical usefulness of positron emission tomography (PET) in the evaluation of myocardial viability. // Rev. Esp. Cardiol. – 1997. – Vol.50. – № 9. – P. 605 – 611. 152 78. Cosar E., O'Connor C. Hibernation, stunning, and preconditioning: historical perspective, current concepts, clinical applications, and future implications. // Seminars in cardiothoracic and vascular anesthesia . – 2003. – Vol. 7. – № 2. – P. 115 – 140. 79. Cuocolo A., Acampa W., Nicolai E., et al. Quantitative thallium-201 and technetium 99m sestamibi tomography at rest in detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction. // J. Nucl. Cardiol. – 2000. – Vol.7. – P. 8 – 15. 80. De Geeter F., Franken P., Knapp F.F. et al. Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction: a study by means of Tc-99m sestamibi and iodine-123-beta-methyl-iodofenyl pentadecanoic acid. // Eur. J. Nucl. Med. - 1994. – Vol. 21. – № 4. - P. 283 – 291. 81. Depre С., Vatner S. Cardioprotection in stunned and hibernating myocardium. // Heart Fail. Rev. – 2007. – Vol. 12. – № 3-4. – P. 307 – 317. 82. Deutsch E., Berger M., Kussmaul W. Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. // Circulation. – 1990. – Vol. 82. – № 6. – P. 2044 – 2051. 83. Di Carli M., Hachamovitch R., Berman D. The art and science of predicting postrevascularization improvement in left ventricular (LV) function in patients with severely depressed LV function. // J. Am. Coll. Cardiol. – 2002. – Vol. 40 . – № 10. – P. 1744 – 1747. 84. Di Carli M., Marcelo F. Predicting improved function after myocardial revascularization. // Curr. Opin. Cardiol. – 1998. – Vol.13. – № 6. – P. 415 – 424. 85. Diamond G., Forrester J., deLuz P., et al. Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. // Am. Heart J. – 1978. – Vol. 95. – P. 204 – 209. 86. Dunning J., Waller J., Smith B., et al. Coronary artery bypass grafting is associated with excellent long-term survival and quality of life: a prospective cohort study. // Ann. Thorac. Surg. – 2008. – Vol. 85. – P. 1988 – 1993. 153 87. Fauteux M.. Treatment of coronary disease with angina perecoronary neuroectomy combined with ligation of the great cardiac vein. // Amer. Heart J. – 1946. – Vol.3. – P. 160 – 169. 88. Favaloro R.G. Saphenous vein graft in the surgical treatment of coronary artery disease: operative technique. // J. Thorac. Cardiovasc. Surg. – 1969. – Vol.58. – P. 178 – 185. 89. Feigl E. Coronary physiology. // Physiol. Rev. – 1983. – Vol. 63. – № 1. – P. 1 – 205. 90. Ferdinandy P., Schulz R., Baxter G. et al. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. // Pharmacol. Rev. – 2007. – Vol. 59. – № 4. – P. 418 – 458. 91. Ferrari R., Ceconi C., Curello S., et al. Left ventricular dysfunction due to the new ischemic outcomes: stunning and hibernation. // J. Cardiovasc. Pharmacol. – 1996. – Vol.28. – Suppl. 1. – P. S18 – S26. 92. Fieschi D. // Arch. Ital. Chir. – 1942. – Vol.63. – P. 303 – 310. 93. Flameng W., Shivalkar B., Spiessens B., et al. PET scan predicts recovery of left ventricular function after coronary artery bypass operation. // Ann. Thorac. Surg. – 1997. – Vol. 67. – № 6. – P. 1694 – 1701. 94. Franken P., De Geeter F., Dendale P. et al. Abnormal free acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. // J. Nucl. Med. – 1994. – Vol. 35. – № 11. – P. 1758 – 1765. 95. Franken P., Hambye A., De Geeter F. BMIPP imaging to assess functional outcome in patients with acute and chronic left ventricular dysfunction. // Int. J. Card. Imaging – 1999. – Vol. 15 – № 1. – P. 27 –34. 96. Gheorghiade M., Bonow R. Chronic heart failure in the United States. A manifestation of coronary artery disease. // Circulation. – 1998. – Vol. 97. – № 3. – P. 282 – 289. 154 97. Ghosh N., Rimoldi O., Beanlands R., et al. Assessment of myocardial ischaemia and viability: role of positron emission tomography. // Europ. Heart Jour. – 2010. – Vol.31. – P. 2984 –2995. 98. Gray R., Maddhai J., Berman D., et al. Scintigraphic and hemodynamic demonstration of transient left ventricular dysfunction immediately after uncomplicated coronary artery bypass grafting. // J. Thorac. Cardiovasc. Surg. – 1979. – Vol. 77. – № 4. – P. 504 – 510. 99. Gross E., Gross G. Ischemic preconditioning and myocardial infarction: an update and perspective. // Drug. Discov. Today Dis. Mech. – 2007. – Vol. 4. – № 3. – Р. 165 –174. 100. Guo Y, Wu W., Zhu X., et al. Exercise-induced late preconditioning is triggered by generation of nitric oxide. // J. Mol. Cell. Cardiol. – 2001. – Vol. 33 . – № 6. – Р. A41. 101. Haasa F., Jennenb L., Heinzmannb U., et al. Ischemically compromised myocardium displays different time-courses of functional recovery: correlation with morphological alterations? // Eur. J. Cardiothorac. Surg. – 2001. – Vol. 20. – № 2. – P. 290 – 298. 102. Hausmann H., Meyer R., Siniawski H., et al. Factors excercising an influence on recovery of hibernating myocardium after coronary artery bypass grafting. // Eur. J. Cardiothorac. Surg. – 2004. – Vol. 26. – № 1. – P. 89 – 95. 103. He Z., Shi R., Wu Y., et al. Direct imaging of exercise-induced myocardial ischemia with fluorine-18–labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease. // Circulation. – 2003. – Vol. 108 – № 10. – P. 1208 – 1213. 104. Hearse D. Myocardial ischemia: can we agree on a definition for the 21st century? // Cardiovasc. Res. – 1994. – Vol. 28 – № 12. – P. 1737 – 1744. 105. Hendel R., Berman D., Di Carli M., et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the american college of cardiology foundation appropriate use criteria task force, the american society 155 of nuclear cardiology, the american college of radiology, the american heart assocaphy, the society for cardiovascular magnetic resonance, and the society of nuclear medicineiation, the american society of echocardiography, the society of cardiovascular computed tomogr tomography, the society for cardiovascular magnetic resonance, and the society of nuclear medicine. // J. Am. Coll. Cardiol. – 2009. – Vol. 53. – Р. 2201 – 2229. 106. Heusch G. Hibernating myocardium. // Physiol. Rev. – 1998. - Vol.78 – № 4. – P. 1055 – 1085. 107. Heusch G., Schulz R. Hibernating myocardium: new answers, still more questions! // Circ. Res. – 2002. – Vol. 91. – P. 863 – 865. 108. Heusch G., Sipido K. Myocardial hibernation: a double-edged sword. // Circ. Res. – 2004. – Vol. 94. – № 8. – P. 1005 – 1007. 109. Heyndrickx G. PRO: Stunning and hibernation: two faces of the same disease. // Journ. of clinic. and basic cardiol. – 2000. – Vol. 3. – № 2. – P. 141 – 142. 110. Heyndrickx G., Millard R., Rilchie R., et al. Regional myocardial functional and electrophysical alteration after brief coronary artery occlusion in conscious dogs. // J. Clin. Invest. – 1975. – Vol. 56. – P. 978 – 985. 111. Horn H., Teichholz L., Cohn P., et al. Augmentation of left ventricular contraction pattern in coronary artery disease by an inotropic catecholamine: the epinephrine ventriculogram. // Circulation. – 1974. – Vol.49. – № 6. – P. 1063 –1071. 112. Hughes G., Landolfo C., et al. Is chronically dysfunctional yet viable myocardium distal to a severe coronary stenosis hypoperfused? // Ann. Thorac. Surg. – 2001. – Vol. 72 . – № 1. – P. 163 –168. 113. Huitink J., Visser F., Bax J., et al. Detection of viability after myocardial infarction: available techniques and clinical relevance – a review. // Int. J. Cardiol. – 1995. – Vol. 51. – № 3. – P. 253 – 266. 156 114. Ikonomidis J., Tumiati L., Weisel R., et al. Preconditioning human ventricular cardiomyocytes with brief episodes of simulated ischemia. // Cardiovasc. Res. – 1994. – Vol. 28. – № 8. – P. 1285 – 1291. 115. Ishihara M., Sato H., Tateishi H., et al. Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: Acute angiographic findings and long-term prognosis. // J. Am. Coll. Cardiol. – 1997. – Vol. 30. – № 4. – P. 970 – 975. 116. Jacklin P., Barrington S., Roxburgh J., et al. Cost-effectiveness of preoperative positron emission tomography in ischemic heart disease. // Ann. Thorac. Surg. – 2002. – Vol. 73. – № 5. – P. 1403 – 1409. 117. Jeroudi M., Cheirif J., Habib G., et al. Prolonged wall motion abnormalities after chest pain at rest in patients with unstable angina: A possible manifestation of myocardial stunning. // Am. Heart. J. – 1994. – Vol. 127. – P. 1241 – 1250. 118. Kelly R., Sluiter W., McFalls E. et al. Hibernating myocardium: is the program to survive a pathway to failure? // Circ. Res. – 2008. – Vol. 102. – № 1. – P. 3 – 5. 119. Kloner R., Allen J., Cox T., et al. Stunned left ventricular myocardium after exercise treadmill testing in coronary artery disease. // Am. J. Cardiol. – 1991. – Vol. 68. – P. 329 –334. 120. Kloner R., Bolli R., Marban E., et al. Medical and cellular implications of stunning, hibernation, and preconditioning. // Circulation. – 1998. – Vol. 97. – № 18. – P. 1848 – 1867. 121. Kloner R., Jennings R. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications. Part I. // Circulation. – 2001. – Vol. 104. – № 24. – P. 2981 – 2989. 122. Kloner R., Jennings R. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications. Part II. // Circulation. – 2001. – Vol.104. – № 31. – Р. 58 – 67. |